178 related articles for article (PubMed ID: 16777986)
1. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism.
Kalra J; Shao Q; Qin H; Thomas T; Alaoui-Jamali MA; Laird DW
Carcinogenesis; 2006 Dec; 27(12):2528-37. PubMed ID: 16777986
[TBL] [Abstract][Full Text] [Related]
2. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis.
McLachlan E; Shao Q; Wang HL; Langlois S; Laird DW
Cancer Res; 2006 Oct; 66(20):9886-94. PubMed ID: 17047050
[TBL] [Abstract][Full Text] [Related]
3. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.
Qin H; Shao Q; Curtis H; Galipeau J; Belliveau DJ; Wang T; Alaoui-Jamali MA; Laird DW
J Biol Chem; 2002 Aug; 277(32):29132-8. PubMed ID: 12042301
[TBL] [Abstract][Full Text] [Related]
4. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms.
Qin H; Shao Q; Thomas T; Kalra J; Alaoui-Jamali MA; Laird DW
Cell Commun Adhes; 2003; 10(4-6):387-93. PubMed ID: 14681046
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes.
Duflot-Dancer A; Mesnil M; Yamasaki H
Oncogene; 1997 Oct; 15(18):2151-8. PubMed ID: 9393973
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration.
Thomas T; Jordan K; Simek J; Shao Q; Jedeszko C; Walton P; Laird DW
J Cell Sci; 2005 Oct; 118(Pt 19):4451-62. PubMed ID: 16159960
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
Zibara K; Awada Z; Dib L; El-Saghir J; Al-Ghadban S; Ibrik A; El-Zein N; El-Sabban M
Sci Rep; 2015 Jul; 5():12598. PubMed ID: 26218768
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
Yang J; Qin G; Luo M; Chen J; Zhang Q; Li L; Pan L; Qin S
Cell Death Dis; 2015 Jul; 6(7):e1829. PubMed ID: 26203858
[TBL] [Abstract][Full Text] [Related]
9. Connexins and gap junctions in mammary gland development and breast cancer progression.
McLachlan E; Shao Q; Laird DW
J Membr Biol; 2007 Aug; 218(1-3):107-21. PubMed ID: 17661126
[TBL] [Abstract][Full Text] [Related]
10. Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo.
Ableser MJ; Penuela S; Lee J; Shao Q; Laird DW
J Biol Chem; 2014 Jan; 289(3):1592-603. PubMed ID: 24297173
[TBL] [Abstract][Full Text] [Related]
11. Role of connexin (gap junction) genes in cell growth control and carcinogenesis.
Yamasaki H; Krutovskikh V; Mesnil M; Tanaka T; Zaidan-Dagli ML; Omori Y
C R Acad Sci III; 1999; 322(2-3):151-9. PubMed ID: 10196667
[TBL] [Abstract][Full Text] [Related]
12. Dynamin 2 interacts with connexin 26 to regulate its degradation and function in gap junction formation.
Xiao D; Chen S; Shao Q; Chen J; Bijian K; Laird DW; Alaoui-Jamali MA
Int J Biochem Cell Biol; 2014 Oct; 55():288-97. PubMed ID: 25263585
[TBL] [Abstract][Full Text] [Related]
13. Connexin-26 is a key factor mediating gemcitabine bystander effect.
Garcia-Rodríguez L; Pérez-Torras S; Carrió M; Cascante A; García-Ribas I; Mazo A; Fillat C
Mol Cancer Ther; 2011 Mar; 10(3):505-17. PubMed ID: 21388975
[TBL] [Abstract][Full Text] [Related]
14. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.
Li Z; Zhou Z; Welch DR; Donahue HJ
Clin Exp Metastasis; 2008; 25(8):893-901. PubMed ID: 18839320
[TBL] [Abstract][Full Text] [Related]
15. Connexin 32 induces pro-tumorigenic features in MCF10A normal breast cells and MDA-MB-231 metastatic breast cancer cells.
Adak A; Unal YC; Yucel S; Vural Z; Turan FB; Yalcin-Ozuysal O; Ozcivici E; Mese G
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118851. PubMed ID: 32918981
[TBL] [Abstract][Full Text] [Related]
16. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells.
Momiyama M; Omori Y; Ishizaki Y; Nishikawa Y; Tokairin T; Ogawa J; Enomoto K
Cancer Sci; 2003 Jun; 94(6):501-7. PubMed ID: 12824874
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential.
Li Z; Zhou Z; Donahue HJ
Clin Exp Metastasis; 2008; 25(3):265-72. PubMed ID: 18193170
[TBL] [Abstract][Full Text] [Related]
18. Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32.
Yano T; Hernandez-Blazquez FJ; Omori Y; Yamasaki H
Carcinogenesis; 2001 Oct; 22(10):1593-600. PubMed ID: 11576997
[TBL] [Abstract][Full Text] [Related]
19. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in gap junctional intercellular communication.
Khoo NK; Zhang Y; Bechberger JF; Bond SL; Hum K; Lala PK
Int J Cancer; 1998 Jul; 77(3):440-8. PubMed ID: 9663608
[TBL] [Abstract][Full Text] [Related]
20. Transport and function of cx26 mutants involved in skin and deafness disorders.
Thomas T; Aasen T; Hodgins M; Laird DW
Cell Commun Adhes; 2003; 10(4-6):353-8. PubMed ID: 14681041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
